1. Home
  2. SNY vs DASH Comparison

SNY vs DASH Comparison

Compare SNY & DASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • DASH
  • Stock Information
  • Founded
  • SNY 1994
  • DASH 2013
  • Country
  • SNY France
  • DASH United States
  • Employees
  • SNY N/A
  • DASH N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • DASH Industrial Machinery/Components
  • Sector
  • SNY Health Care
  • DASH Industrials
  • Exchange
  • SNY Nasdaq
  • DASH Nasdaq
  • Market Cap
  • SNY 116.5B
  • DASH 109.4B
  • IPO Year
  • SNY N/A
  • DASH 2020
  • Fundamental
  • Price
  • SNY $49.58
  • DASH $244.10
  • Analyst Decision
  • SNY Buy
  • DASH Buy
  • Analyst Count
  • SNY 3
  • DASH 32
  • Target Price
  • SNY $65.00
  • DASH $266.16
  • AVG Volume (30 Days)
  • SNY 2.3M
  • DASH 3.8M
  • Earning Date
  • SNY 10-24-2025
  • DASH 10-29-2025
  • Dividend Yield
  • SNY 3.23%
  • DASH N/A
  • EPS Growth
  • SNY 118.56
  • DASH N/A
  • EPS
  • SNY 8.65
  • DASH 1.76
  • Revenue
  • SNY $53,714,621,258.00
  • DASH $11,895,000,000.00
  • Revenue This Year
  • SNY $2.01
  • DASH $25.42
  • Revenue Next Year
  • SNY $6.82
  • DASH $20.59
  • P/E Ratio
  • SNY $11.21
  • DASH $138.92
  • Revenue Growth
  • SNY 15.65
  • DASH 23.78
  • 52 Week Low
  • SNY $44.73
  • DASH $122.32
  • 52 Week High
  • SNY $60.12
  • DASH $278.15
  • Technical
  • Relative Strength Index (RSI)
  • SNY 51.60
  • DASH 46.74
  • Support Level
  • SNY $50.07
  • DASH $244.04
  • Resistance Level
  • SNY $51.60
  • DASH $248.81
  • Average True Range (ATR)
  • SNY 0.61
  • DASH 6.42
  • MACD
  • SNY 0.00
  • DASH -1.37
  • Stochastic Oscillator
  • SNY 40.06
  • DASH 35.33

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

About DASH DoorDash Inc.

Founded in 2013 and headquartered in San Francisco, DoorDash is an online delivery demand aggregator. Consumers can use its app to order food items on-demand for delivery or in-store from merchants. Through the acquisition of Wolt in 2022, the firm also provides this service in Europe and Asia. DoorDash creates a marketplace for merchants to establish a presence online, market their offerings, and meet demand through delivery. The firm provides similar service to nonrestaurant businesses, such as grocery, retail, and pet supplies. Dash is also rolling out nascent technology like drone delivery in an effort to continually innovate and provide the best possible service to supply-side and demand-side contingents of its marketplace.

Share on Social Networks: